Abcellera Biologics Inc ABCL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
9.85UNCH (UNCH)
Volume
16,408
Close
9.85quote price arrow down-0.12 (-1.20%)
Volume
1,890,570
52 week range
5.42 - 20.30
Loading...
  • Open9.82
  • Day High9.90
  • Day Low9.57
  • Prev Close9.97
  • 52 Week High20.30
  • 52 Week High Date09/30/21
  • 52 Week Low5.42
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap2.809B
  • Shares Out285.14M
  • 10 Day Average Volume1.73M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-31.12

KEY STATS

  • Open9.82
  • Day High9.90
  • Day Low9.57
  • Prev Close9.97
  • 52 Week High20.30
  • 52 Week High Date09/30/21
  • 52 Week Low5.42
  • 52 Week Low Date05/12/22
  • Market Cap2.809B
  • Shares Out285.14M
  • 10 Day Average Volume1.73M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-31.12

RATIOS/PROFITABILITY

  • EPS (TTM)0.64
  • P/E (TTM)15.43
  • Fwd P/E (NTM)-40.37
  • EBITDA (TTM)286.599M
  • ROE (TTM)18.38%
  • Revenue (TTM)507.34M
  • Gross Margin (TTM)-
  • Net Margin (TTM)39.49%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Abcellera Biologics Inc

 

Profile

MORE
AbCellera Biologics Inc. (AbCellera) is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug...
Carl Hansen Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Andrew Booth
Chief Financial Officer
Address
2215 Yukon Street
Vancouver, BC
V5Y 0A1
Canada

Top Peers

SYMBOLLASTCHG%CHG
ACAD
ACADIA Pharmaceuticals Inc
16.14-0.65-3.87%
GLPG
Galapagos NV
42.27-0.62-1.45%
FOLD
Amicus Therapeutics Inc
10.28-0.41-3.84%
RARE
Ultragenyx Pharmaceutical Inc
40.55-0.72-1.74%
INSM
Insmed Inc
21.87-0.91-3.99%